Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$1.06 - $1.67 $7,456 - $11,746
-7,034 Reduced 4.38%
153,594 $178,000
Q4 2023

Feb 08, 2024

SELL
$1.26 - $1.79 $81,155 - $115,292
-64,409 Reduced 28.62%
160,628 $271,000
Q3 2023

Nov 07, 2023

BUY
$1.61 - $2.54 $31,971 - $50,439
19,858 Added 9.68%
225,037 $407,000
Q2 2023

Aug 09, 2023

BUY
$1.14 - $1.95 $92,932 - $158,964
81,520 Added 65.92%
205,179 $381,000
Q1 2023

May 08, 2023

BUY
$1.2 - $2.19 $10,670 - $19,473
8,892 Added 7.75%
123,659 $164,000
Q4 2022

Feb 07, 2023

BUY
$1.63 - $3.52 $23,938 - $51,694
14,686 Added 14.67%
114,767 $193,000
Q3 2022

Nov 01, 2022

BUY
$0.73 - $3.74 $1,572 - $8,055
2,154 Added 2.2%
100,081 $312,000
Q2 2022

Aug 04, 2022

BUY
$2.2 - $4.2 $215,439 - $411,293
97,927 New
97,927 $233,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.